Relation of HLA Class I and II Supertypes with Spontaneous Clearance of Hepatitis C Virus
暂无分享,去创建一个
M. Carrington | Mardge H. Cohen | R. Greenblatt | K. Anastos | M. Young | S. Gange | C. Thio | Xiao-jiang Gao | X. Xue | M. Peters | H. Strickler | H. Minkoff | A. Kovacs | M. Kuniholm | A. Sette | D. Marti | Xiaojiang Gao
[1] Heiyoung Park,et al. Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion. , 2012, The Journal of infectious diseases.
[2] Bjoern Peters,et al. Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes , 2011, Immunogenetics.
[3] O. Lund,et al. NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure , 2010, Immunome research.
[4] J. Goedert,et al. Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia , 2010, Hepatology.
[5] P. Shapshak,et al. A HLA-DRB supertype chart with potential overlapping peptide binding function , 2010, Bioinformation.
[6] Kelly P Burke,et al. Hepatitis C virus evasion of adaptive immune responses: a model for viral persistence , 2010, Immunologic research.
[7] Chia-Ling Kuo,et al. What's the best statistic for a simple test of genetic association in a case‐control study? , 2009, Genetic epidemiology.
[8] L. Gardner,et al. Human Leukocyte Antigen Class I Supertypes and HIV-1 Control in African Americans , 2009, Journal of Virology.
[9] K. Sugimoto,et al. Human leukocyte antigen class II associations with hepatitis C virus clearance and virus‐specific CD4 T cell response among Caucasians and African Americans , 2008, Hepatology.
[10] Morten Nielsen,et al. Quantitative Predictions of Peptide Binding to Any HLA-DR Molecule of Known Sequence: NetMHCIIpan , 2008, PLoS Comput. Biol..
[11] H. Blum,et al. Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine , 2008, Biological chemistry.
[12] Bjoern Peters,et al. HLA class I supertypes: a revised and updated classification , 2008, BMC Immunology.
[13] Tin Wee Tan,et al. In silico grouping of peptide/HLA class I complexes using structural interaction characteristics , 2007, Bioinform..
[14] Tomer Hertz,et al. Identifying HLA supertypes by learning distance functions , 2007, Bioinform..
[15] Ellis L Reinherz,et al. Definition of MHC Supertypes Through Clustering of MHC Peptide Binding Repertoires , 2004, ICARIS.
[16] Todd M. Allen,et al. Mutually Exclusive T-Cell Receptor Induction and Differential Susceptibility to Human Immunodeficiency Virus Type 1 Mutational Escape Associated with a Two-Amino-Acid Difference between HLA Class I Subtypes , 2006, Journal of Virology.
[17] B. Bell,et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. , 2006, Journal of hepatology.
[18] E. Karita,et al. Human Leukocyte Antigen B58 Supertype and Human Immunodeficiency Virus Type 1 Infection in Native Africans , 2006, Journal of Virology.
[19] M. Alter,et al. The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002 , 2006, Annals of Internal Medicine.
[20] Irini A. Doytchinova,et al. In Silico Identification of Supertypes for Class II MHCs1 , 2005, The Journal of Immunology.
[21] O. Pybus,et al. The hepatitis C virus epidemic among injecting drug users. , 2005, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[22] Paul Shapshak,et al. A framework to sub-type HLA supertypes. , 2005, Frontiers in bioscience : a journal and virtual library.
[23] D. Flower,et al. Identifiying Human MHC Supertypes Using Bioinformatic Methods , 2004, The Journal of Immunology.
[24] O. Lund,et al. Definition of supertypes for HLA molecules using clustering of specificity matrices , 2004, Immunogenetics.
[25] J. Goedert,et al. Viral clearance occurs very early during the natural resolution of hepatitis C virus infection in persons with haemophilia , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.
[26] John D. Storey,et al. Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[27] James Theiler,et al. Advantage of rare HLA supertype in HIV disease progression , 2003, Nature Medicine.
[28] E L Murphy,et al. Prevalence of hepatitis C virus infection in the United States. , 1999, The New England journal of medicine.
[29] J. Sidney,et al. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism , 1999, Immunogenetics.
[30] Inda,et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. , 1999, The New England journal of medicine.
[31] A Sette,et al. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C. , 1999, Journal of immunology.
[32] L. Mitchell,et al. A new categorization of HLA DR alleles on a functional basis. , 1998, Human immunology.
[33] P. Cano,et al. A geometric study of the amino acid sequence of class I HLA molecules , 1998, Immunogenetics.
[34] J. Emparanza,et al. [The prevalence of hepatitis C virus infection]. , 1998, Gastroenterologia y hepatologia.
[35] A. Sette,et al. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. , 1997, The Journal of clinical investigation.
[36] A Sette,et al. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. , 1996, Immunology today.
[37] C Crimi,et al. Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome. , 1996, International immunology.
[38] M F del Guercio,et al. Several HLA alleles share overlapping peptide specificities. , 1995, Journal of immunology.
[39] S. S. Young,et al. Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment , 1993 .
[40] Y. Chaubey. Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment , 1993 .